Middlebrook will report directly to CEO and president Keith Grossman.
“We’re pleased to have a leader of Don’s caliber join Nevro to advance our clinical pipeline and oversee our global regulatory and quality initiatives,” Grossman said in a news release. “As a combined organization under Don’s leadership, we are improving our efficiency and continuing our commitment to maintaining the highest levels of clinical, regulatory and quality compliance throughout our organization.”
Middlebrook joins Nevro with more than 30 years of senior leadership experience in regulatory affairs, clinical affairs and quality assurance in the medical device industry. Most recently he served as a regulatory and clinical affairs consultant for St. Jude Medical since its acquisition of Thoratec in 2015, where he served as VP of corporate quality and regulatory affairs for 19 years. He has also held a number of leadership positions at Chiron Vision and Baxter International.